Defects in the detection and repair of DNA double-strand breaks (DSBs) have been causatively linked to tumourigenesis. Moreover, inhibition of DNA damage responses (DDR) can increase the efficacy of cancer therapies that rely on generation of damaged DNA. DDR must occur within the context of chromatin, and there have been significant advances in recent years in understanding how the modulation and manipulation of chromatin contribute to this activity. One particular covalent modification of a histone variant-the phosphorylation of H2AX-has been investigated in great detail and has been shown to have important roles in DNA DSB responses and in preventing tumourigenesis. These studies are reviewed here in the context of their relevance to cancer therapy and diagnostics. In addition, there is emerging evidence for contributions by proteins involved in mediating higher order structure to DNA DSB responses. The contributions of a subset of these proteins-linker histones and high-mobility group box (HMGB) proteins-to DDR and their potential significance in tumourigenesis are discussed.
Introduction
Genomes of tumour cells exhibit multiple alterations from the parent cells, and it is now well established that tumourigenesis is a multistep process of genetic alterations. These alterations allow the cell to acquire characteristics that are universal among tumours and have been referred to as the 'hallmarks of cancer' (Hanahan and Weinberg, 2000) . It is estimated that this is achieved in 4-7 rate-limiting stochastic events (Hanahan and Weinberg, 2000) . Consequently, genomic instability has been termed as an 'enabling characteristic' of cancer, since the loss of systems to ensure genomic integrity allow the cell to more easily acquire these genetic changes (Hanahan and Weinberg, 2000) . In fact, more recent work proposes that chromosomal instability is likely to be a driving force in the process of tumourigenesis (Michor, 2005) . This suggests that the ability of cells to detect and, appropriately and efficiently, respond to DNA lesions is critical in preventing the onset of tumourigenesis.
One of the most dangerous DNA lesions a cell can sustain is a DNA double-strand break (DSB). If left unrepaired, a single DSB can be lethal, and can also result in chromosomal translocations, deletions and loss of genetic information. In eukaryotes, there are two main pathways for repairing DSBs; homologous recombination (HR) and nonhomologous end joining. In addition to the repair activities, cells have pathways dedicated to the detection and signalling of these dangerous lesions in order to orchestrate the appropriate response, including cell cycle checkpoints and transcriptional upregulation.
Not surprisingly, it has been known for some time that defects in the DNA damage response (DDR) pathway, such as the Mre11, Rad50, Nbs1 (MRN) complex (for review, see Williams et al., 2007) and in the kinases ataxia telangiectasia mutated (ATM) and ATM and RAD3-related (ATR) (for review, see Jackson, 2002; Lavin et al., 2006) , are associated with cancer predisposition syndromes in humans, and disruption of DNA repair systems in mouse models leads to an increased risk of cancer (Jackson, 2002; Lavin et al., 2006; Williams et al., 2007) . Obviously, one critical function of these pathways is to respond to exogenously induced DNA damage. However, programmed DSBs are created in lymphocytes undergoing class switch recombination or V(D)J recombination. Importantly, components of the DDR program are essential for protecting the genome from chromosome translocations in lymphocytes (for example, Vogel et al., 1999) . Unless the breaks created during these processes are efficiently resolved, they can serve as substrates for chromosome translocation, and deficiency in ATM promotes these aberrant joining events (Reina-San-Martin et al., 2003; Bredemeyer et al., 2006; Franco et al., 2006; Ramiro et al., 2006) .
Interestingly, recent work from two labs has demonstrated that the DDR are activated early during tumourigenesis (Bartkova et al., 2005; Gorgoulis et al., 2005) . This was thought to be due to DNA damage caused by increased replicative stress in rapidly dividing pre-neoplastic lesions. These findings demonstrate the central importance of the DDR pathway, which acts as an inducible barrier against tumour progression and genetic instability. Once overcome, the cells are subsequently vulnerable to accumulating additional genetic changes. Clearly, therefore, understanding the mechanisms of DDR is of central importance to cancer biology.
Chromatin and the DNA damage response
Clearly, these DDR must occur within the context of chromatin. At its simplest level, chromatin is made up of DNA wrapped around an octamer of histone proteins (two each of H2A, H2B, H3 and H4) to form a nucleosome. The histones have histone fold domains, which are important for the formation of the central structure of the nucleosome, and flexible tail domains, which protrude from the nucleosome core particle (Luger et al., 1997) . The packaging of DNA in this manner is generally inhibitory to processes such as transcription and replication, and cells have numerous mechanisms by which this structure can be manipulated to make it more amenable to these activities. Broadly, they can be placed into two groups; the addition of covalent modifications to the histone proteins, and the activity of ATP-dependent chromatin remodelling activities that use the energy derived from the hydrolysis of ATP to alter the contacts between the DNA and histone proteins.
Chromatin has the ability to form compact structures well beyond the initial level of nucleosomes. There are a number of factors that influence the formation of these higher order structures, including linker histones and high-mobility group (HMG) proteins. These are abundant architectural chromatin proteins found throughout eukaryotic evolution. Not surprisingly, these proteins are also subjected to complex control by numerous covalent modifications that affect their chromatinbinding activities and protein-protein associations. Chromatin is, therefore, a highly complex polymer capable of extraordinary variability in both structure and composition.
There has been a great deal of research into the changes in chromatin structure that occur in response to DNA damage. In particular, there are many covalent modifications of histones that are now known to be important for DDR, and there is likely to be a pattern of modifications on histones in the proximity of DNA DSBs that contributes to DDR. It is also now apparent that multiple ATP-dependent chromatin remodelling complexes contribute to cellular survival after DNA damage and play a role directly at the sites of DNA damage. These events have been extensively reviewed elsewhere (Peterson and Cote, 2004; Foster and Downs, 2005; Morrison and Shen, 2005; van Attikum and Gasser, 2005; Costelloe et al., 2006; Downs et al., 2007) . Moreover, the contribution of chromatin modifying complexes and enzymes to tumourigenesis was the subject of a recent issue of Oncogene reviews (volume 26, issue 37). Therefore, in this review, the focus will be limited to two topics that have received less attention. First, an important role for proteins involved in mediating higher order chromatin structure, the linker histones and HMG proteins, in DNA DSB responses is emerging. Second, recent studies have examined the ability to exploit one particular DNA damage-dependent chromatin alteration-the phosphorylation of H2AX-for clinical applications.
The linker histone and DNA damage responses Linker histones are found throughout eukaryotic evolution (Ausio, 2000) . In lower eukaryotes, they do not appear to be essential for viability (Ausio, 2000; Harvey and Downs, 2004) . For example, in budding yeast, there is a single gene encoding a linker histone, termed HHO1, and cells lacking this gene show very little phenotypic alterations (Harvey and Downs, 2004) . In higher eukaryotes, multiple isoforms of linker histones exist. In mice, disruption any one of the eight linker histone genes does not result in lethality, and it appears that there is upregulation of the remaining genes in order to compensate for the loss (Alami et al., 2003) . However, once three genes are disrupted and the total amount of linker histone falls significantly, this is an embryonic lethal event (Fan et al., 2005) . This suggests that for the function required in higher eukaryotes to sustain viability, the different linker histone genes are functionally redundant and it is the overall level of linker histone protein in the cell that is critical. Similarly, in chicken DT40 cells, while there are six genes encoding linker histones, the presence of a single linker histone gene is sufficient for viability (Hashimoto et al., 2007) .
In yeast, it has been demonstrated that the loss of the linker histone results in hyper-resistance to methyl methane sulfonate (MMS). By using a combination of genetic approaches, a model in which the linker histone acts to inhibit the HR pathway was proposed (Downs et al., 2003) . While the behaviour of the linker histone after treatment of cells with MMS was not directly examined, it would be reasonable to hypothesize that there may be some regulation of linker histones in response to DNA damage. In particular, the dissociation of Hho1 from chromatin would be predicted to facilitate the repair of the DNA lesions by HR.
Interestingly in this regard, in mammalian cells, a population of all five of the linker histone isoforms that are ubiquitously expressed in somatic cells re-localize from the nucleus to the cytosol in response to ionizing radiation ( Figure 1 ; Konishi et al., 2003) . However, the effect of this re-localization on HR activity was not examined. Rather, in this study, the authors had set out to identify pro-apoptotic cellular factors that induce cytochrome c release from mitochondria by using cytosolic extracts prepared from cells treated with ionizing radiation (IR). Although all five linker histones were detectable in the cytosol after cells were treated with IR, they found that only H1.2 was capable of efficiently promoting cytochrome c release in this assay, and this activity was dependent on the presence of Bak.
The release of H1.2 from the nucleus was dependent on p53, and occurred specifically in response to agents that caused DNA DSBs, such as IR and etoposide, but not in response to ultraviolet-induced apoptosis. Consistent with a direct role in mediating IR-induced apoptosis, inhibition of H1.2 with anti-sense RNA resulted in reduced apoptosis and very little detectable mitochondrial release of cytochrome c. Therefore, while the significance of IR-induced re-localization of all linker histones to the cytosol is still unknown, H1.2 plays an important role in mediating apoptosis in response to DNA DSBs.
The contribution of linker histones to DDR was recently examined in chickens using DT40 cells (Hashimoto et al., 2007) . Interestingly, the authors found that only one linker histone, H1.R, contributes to cellular survival after exposure to DNA damage. However, in contrast to what might be predicted based on the yeast studies, the cells lacking H1.R were hypersensitive rather than hyper-resistant to MMS. Yet, as in yeast, this appeared to be specifically relevant to HR, as H1.R À/À /Rad54 À/À double-mutant cell line was no more sensitive than either single. In contrast, a H1.R À/À showed additive effects when combined with Ku70
. The mechanism by which H1.R contributes to cellular survival is not clear, since H2AX phosphorylation and Rad51 foci formation after MMS appear normal in the absence of H1.R, and there is no obvious defect in a specific HR assay using an inducible restriction enzyme and looking at recombination of two tandem NeoR cassettes.
The reason for the opposing activities of chicken H1.R and yeast Hho1 in HR are not clear. One possibility is that when multiple isoforms exist, they are able to become more specialized. In yeast, where only one linker histone exists, there may be pressure to maintain certain activities. It is possible that globally, inhibition of HR is more advantageous than facilitation of this pathway. It has been shown that inappropriate recombination can result in accelerated aging, and indeed, we found that the linker histone in yeast is important for maintaining a full life span. In chickens however, if one linker histone that makes up less than one-third of the total linker histone in cells promotes HR, it may not be globally deleterious to the cell. Moreover, one or more of the other linker histones could inhibit HR. This would allow higher eukaryotes the potential for much greater regulation over genomic recombination.
One important aspect of this potential ability to regulate recombination is the affect on regulation and maintenance of telomeres. In higher eukaryotes, telomerase is inactive in somatic cells, and the 'end replication' problem contributes to the mortality of these cells. In the majority of tumours, the cells get around this problem by reactivating telomerase. However, in a significant proportion of cancer Inflammation signalling Figure 1 The role of chromatin proteins during senescence, apoptosis and necrosis. In response to IR, linker histones (circles) are relocalized to the cytosol and one isoform (H1.2, blue) triggers apoptosis via interaction with the mitochondria (gray), while HMGB proteins (blue diamonds) are actively retained in the chromatin. In contrast, during necrosis and in response to stress (for some cell types) HMGB1 is released and acts to signal an inflammatory response. Linker histones are lost when cells undergo senescence. Gray bars represent chromatin. See text for details.
cells, the need for telomerase is circumvented by hyperrecombination of the repetitive sequences at telomeres to maintain the ends of their chromosomes in what has been dubbed the Alternative Lengthening of Telomeres, or ALT, pathway (Neuman and Reddel, 2002) . In yeast, when telomerase is inactivated, most cells die, but a minority of cells survive this catastrophic event by using a similar mechanism, which is also dependent on HR (Teng and Zakian, 1999) . We found that the ability of yeast cells to use this pathway is negatively influenced by the linker histone (Downs et al., 2003) . If conserved, this would imply that linker histones can act as tumour suppressor genes by inhibiting immortalization via the ALT pathway (Table 1) .
While not directly relating to DNA DSB repair, it has been found recently that linker histones are lost during the process of cellular senescence (Funayama et al., 2006) . However, it has been proposed that the senescence pathway is important for preventing tumourigenesis and this is therefore potentially relevant to the development of cancer (Campisi, 2005) . In this study, the authors found that in a variety of cell types, there was a global loss of linker histones during senescence (Figure 1 ; Funayama et al., 2006) . Interestingly, this correlates with the compaction of chromatin into visible heterochromatic structures. While the linker histone is normally associated with compaction of chromatin, the authors also find that a number of histone modifications normally associated with condensed chromatin are not present in these senescent heterochromatic structures, suggesting that this is an atypical form of condensed chromatin. In addition, the authors also found a proportionate increase in this heterochromatin of the high-HMGA2 protein. This would suggest that replacing linker histones with HMGA2 might help to create a heterochromatic structure required for cellular senescence. In this model, linker histones would potentially be oncogenic if they could inappropriately prevent senescence. However, it is not clear at this stage whether these changes are causative.
What is emerging from these studies is that unlike the ability of linker histones to function redundantly in higher eukaryotes with respect to their essential function, the different isoforms can play highly specialized roles in DDR with little if any overlap (Konishi et al., 2003; Hashimoto et al., 2007) . It will therefore be very interesting to begin to more thoroughly dissect the activities of these individual proteins in DNA repair activities.
High-mobility group box proteins and DNA double-strand break repair
In addition to linker histones, HMG proteins are abundant cellular proteins that regulate chromatin structure (for review, see Bianchi and Agresti, 2005) . HMG proteins have been divided into three families based on their domain structure; HMGA (which contain AT hooks), HMGB (which contain HMG Box domains) and HMGN (which contain Nucleosome-binding activity).
While there is evidence that all three families impinge either directly or indirectly on the maintenance of genomic stability (Reeves and Adair, 2005) , the HMGB family has been implicated specifically in DNA DSB repair activities.
While some proteins containing an HMG box are sequence specific DNA binding proteins, the HMG boxes of the abundant chromatin architectural proteins HMGB1 and HMGB2 have been shown to bind to DNA in a sequence-independent manner (for review, see Thomas and Travers, 2001; Travers, 2003) . These proteins are characterized by two tandem HMG boxes followed by a basic linker region and an acidic Cterminal tail. The binding of these proteins to DNA induces a bend, and consequently, the proteins have a higher affinity for pre-bent DNA. In addition, HMGB proteins preferentially bind crossover structures and hemicatenated DNA. These activities may suggest a role for HMGB proteins during HR, where these types of structures exist as intermediates.
While no evidence currently exists to support a role for HMGB proteins in mediating HR, there is some reason to speculate that HMGB1 may play a role in non-homologous end joining (NHEJ). Specifically, a number of reports found that the mammalian HMGB protein HMGB1 is able to promote end joining between DNA molecules in vitro. These proteins were able to very efficiently promote intramolecular ligation events (Nagaki et al., 1998; Yamanaka et al., 2002) , and this is likely to be due to the ability of these proteins to bend the DNA such that juxtaposition of the ends is energetically more favourable and therefore promotes successful ligation events. Somewhat more interestingly, intermolecular ligations were also promoted by the presence of HMGB1 (Stros et al., 2000; Yamanaka et al., 2002) , which is more relevant to NHEJ activity in the context of the genome. Moreover, using pull-down assays with DNA molecules labelled with either biotin or radioactivity, HMGB1 appears to be able to promote the noncovalent association of two DNA molecules (Stros et al., 2000) . Notably, however, there is very little evidence to suggest that this activity has any biological relevance to NHEJ in vivo. One exception to this is a study showing that cells overexpressing HMGB1 or HMGB2 have higher rates of integration of transfected exogenous DNA than the parental cells (Ueda et al., 2002) . However, it is not clear whether the ability to promote the association of two DNA molecules is the activity responsible for this effect. It may instead be an effect of altering chromatin structure, affecting gene regulation or binding to integration intermediates, and this will need to be investigated further. As discussed above, V(D)J recombination is the process in higher eukaryotes, which allows the generation of diversity in immunoglobulin-encoding genes. During this process, the RAG recombinases create DNA DSBs in the genome, which are subsequently processed and repaired by NHEJ. As previously mentioned, defects in the ability to detect and repair these programmed DSBs is therefore very deleterious, and can lead to increased levels of tumourigenesis in these cell types. It has been known for some time that mammalian HMGB proteins, HMGB1 and HMGB2, facilitate V(D)J recombination. Rather than affecting NHEJ, however, this is because HMGB proteins promote DNA binding and cleavage by the RAG proteins (for example Bergeron et al., 2005; Dai et al., 2005 and references therein) . Given the behaviour of the HMGB proteins in end joining assays in vitro, it will be interesting to see whether they have additional, subsequent roles in V(D)J recombination in which they promote the repair of the DSBs by NHEJ.
While not specifically related to DNA DSB repair, HMGB proteins show an additional behaviour which impacts significantly on tumourigenesis (Figure 1 ). When stressed, some cell types are able to secrete HMGB1 and this results in an inflammatory response (for review, see Raucci et al., 2007) . Moreover, HMGB1 is also passively released by necrotic cells, which has the same inflammatory consequence (Scaffidi et al., 2002) . This response is mediated by HMGB1 binding to the receptor for advanced glycation end products (RAGE). Crucially, blocking this signalling pathway suppresses tumour growth and metastases (Taguchi et al., 2000) , indicating that this inflammatory response is an important consequence in the development of cancer.
On the surface, this nuclear release of HMGB1 in response to stress appears to be similar to the relocalization of the linker histone from the nucleus in response to apoptosis-inducing treatment with IR. Interestingly, however, it was demonstrated that HMGB1 is not released from apoptotic cells induced with etoposide or H 2 O 2 (Scaffidi et al., 2002) . This suggests that the use of nuclear proteins as signals in response to different types of stress is more specialized. When undergoing apoptosis, cells sequester HMGB1 in the nucleus perhaps in order to avoid an unnecessary inflammatory response. It appears that the ability of cells to sequester HMGB1 to chromatin depends on the acetylation status of chromatin, and pretreatment with the histone deacetylase (HDAC) inhibitor Trichostatin A (TSA) prevents retention of HMGB1 (Scaffidi et al., 2002) .
As previously mentioned, HDAC inhibitors have strong anti-proliferative effects on transformed cells relative to normal cells and enhance the sensitivity of cells to radiation as well as chemotherapeutics. A number of these inhibitors are now in clinical trials and the data appear very promising (Xu et al., 2007) . However, it may be worthwhile investigating whether these have the unintended consequence of promoting HMGB1 release and consequently inflammatory responses. The use of HDAC inhibitors in combination with agents that block the HMGB1-RAGE signalling pathway may prove to be useful.
H2AX and cancer
In addition to the incorporation of the four core histones into nucleosomes, histone variants also exist and can affect the structure and behaviour of chromatin. The H2AX variant of histone H2A has an extended C-terminal tail that contains a consensus site for phosphorylation by ATM and ATR (Redon et al., 2002; Foster and Downs, 2005) . The phosphorylation of this site in response to DNA damage is one of the earliest and most robust alterations to chromatin known to occur in response to DNA damage. While budding yeast do not have an H2AX variant, the phosphorylated motif exists on the core histone H2A protein (Foster and Downs, 2005) and is phosphorylated by the homologues of ATM and ATR (Mec1 and Tel1) in response to DNA damage, respectively.
The potential exploitation of H2AX phosphorylation for clinical applications related to cancer biology has recently been investigated in several ways. First, H2AX phosphorylation has been shown to act as a readout of cellular radiosensitivity, thus acting to predict the efficacy of radiotherapy (Taneja et al., 2004; Munshi et al., 2006) . This suggests that H2AX phosphorylation could be used to monitor patient responses to chemoand radiotherapies (for review, see Kao et al., 2006) . In support of this possibility, the presence of H2AX foci was recently examined in skin biopsies of patients undergoing radiotherapy and found to reproducibly correspond with the dose given in a linear manner (Qvarnstrom et al., 2004) .
Because tumour cells are dividing much more rapidly than most other somatic cells, agents that cause DNA damage can be used to selectively kill them. In this case, residual DNA damage detection and repair activities in the tumour cells are problematic as they can allow some of these cells to evade IR-or chemotherapy-induced cell death. Inhibition of the DDR has been shown to increase the radiosensitivity of cells and can therefore function to increase the efficacy of existing cancer therapies (for review, see Madhusudan and Middleton, 2005) . Specifically, numerous reports have demonstrated that when radiotherapy is combined with drugs inhibiting the activity of the ATM and ATR family of kinases, there is greater cell death than radiotherapy alone (for example, Cowell et al., 2005 and references therein). It has been shown that the gene encoding H2AX acts as a tumour suppressor gene in mice (Bassing et al., 2003; Celeste et al., 2003) and repression of the H2AX gene in mouse teratocarcinoma cells results in increased radiosensitivity (Yoshida and Morita, 2004) , suggesting that phosphorylation of H2AX provides an additional target for sensitizing cells to IR. Indeed, treatment of tumour cells with peptide mimics of the phosphorylated H2AX tail had no effect on un-irradiated tumour cells but enhanced cell death in irradiated radioresistant tumour cells (Taneja et al., 2004) . Together, these data support H2AX phosphorylation as a potential therapeutic target for improving the efficacy of radiotherapy. Because H2AX is also phosphorylated in response to DNA damage caused by many chemotherapeutic agents (described in more detail below), it is not unreasonable to assume that H2AX phosphorylation may provide a target for improving the efficacy of chemotherapy as well.
Many drugs are identified as chemotherapeutic agents based on their growth inhibitory activity towards cells without any mechanistic insights about the molecular basis behind it. Thus, H2AX phosphorylation has been used to investigate the cellular and molecular effect of known anti-cancer agents, such as aminoflavone, which was consequently found to activate the DDR (Meng et al., 2005) . Inhibitors of HDACs function as very promising anti-cancer agents, but the mechanism by which they function in this regard is not known (Xu et al., 2007) . It has been postulated that they function to alter the transcription of oncogenes or tumour suppressor genes that have been misregulated due to epigenetic alterations common in cancer. Another possible mechanism is that they influence the DNA repair pathway, which is regulated by acetylation (Hasan and Hottiger, 2002; Sun et al., 2005; Murr et al., 2006) . Recently, it has been found that treatment of cells with HDAC inhibitors enhances the sensitivity of cancer cells to ionizing radiation and DNA damage inducing chemotherapies (Dokmanovic and Marks, 2005) . H2AX phosphorylation was used to investigate this phenomenon and the results suggest that HDAC inhibitors function as anticancer agents, at least in part, by inhibiting the repair of DNA damage (Munshi et al., 2006; Qian et al., 2006) . Finally, the use of H2AX phosphorylation has been adapted to determine whether drug treatments, such as norethindrone used in hormone replacement therapy, are genotoxic (Gallmeier et al., 2005) .
Regulation of chromatin and tumourigenesis: a causative link?
As discussed above, the loss of DDR is an enabling characteristic which allows the generation of alterations to the genome that can result in tumourigenesis (Hanahan and Weinberg, 2000) . Also described above, the most well-studied chromatin modification in DDR is the phosphorylation of H2AX and this has now been exploited for use in clinical applications, and elegant studies in mouse systems have demonstrated that the gene encoding H2AX functions as a tumour suppressor gene indicating a direct role in preventing tumourigenesis (Bassing et al., 2003; Celeste et al., 2003) .
Two recent reports identify two further enzymes that affect chromatin structure whose loss can lead to the induction of tumours suggesting a causal link with tumourigenesis (Peters et al., 2001; Gaudet et al., 2003) . First, mice carrying a hypomorphic allele of the DNA methyltransferase 1 gene developed aggressive T-cell lymphomas (Gaudet et al., 2003) . While the mechanism by which this occurs was not definitively elucidated, the authors found an effect on chromosomal instability and postulated that this was the mechanism by which the mice developed tumours. In addition, mice deficient in the Suv39 h histone methyltransferase, which targets histone H3 K9, display chromosomal instabilities that are associated with increased rates of tumourigenesis (Peters et al., 2001) . It seems reasonable to predict that more genes involved in chromatin modulation will be found to impact on tumourigenesis, and at least some of these will do so via influencing DDR.
Histone modifications and cancer therapy and diagnostics: beyond H2AX
As discussed above with regard to H2AX phosphorylation, inhibition of activities that promote or facilitate DNA repair can be clinically useful. Novel changes in chromatin structure, modification patterns and organization in response to DNA damage therefore have relevance to cancer biology since the identification of additional DNA damage-dependent activities can identify novel targets for therapeutic drugs.
In addition to therapeutic value, identification of novel DNA damage-dependent chromatin alterations can serve as new biomarkers. Again, as described above, H2AX has been exploited in this way. Importantly however, studies have also found that H2AX phosphorylation does not function reliably as a predictor of radiosensitivity in all cases (Mahrhofer et al., 2006; Yu et al., 2006) . Identification of other DNA damagedependent modifications could provide more accurate biomarkers. More likely, these could be used in combination with our existing knowledge to provide more robust biomarkers and drug targets.
Clearly, in light of the studies described above, the DNA methylation patterns and levels of H3 K9 methylation in tumours may turn out to be useful in this regard. In addition, two studies examined changes in histone modifications that take place during tumourigenesis without examining causality (Seligson et al., 2005) . In the first, histone H4 was isolated and analysed by mass spectroscopy. The authors found that a decrease in acetylation of K16 and trimethylation of K20 was commonly found in cancerous cells and tissues compared with their normal counterparts (Fraga et al., 2005) . In the second study, specific antibodies against five modifications (acetylated h3 K9, K18 and H4 K12 and dimethylated H4 R3 and H3 K4) were used to examine prostate tissue. The pattern of modifications was found to be a strong predictor of outcome, indicating that histone modification can be used to determine prognosis (Seligson et al., 2005) . One intriguing possibility is that some of these changes may be a part of the DDR that is activated during tumourigenesis (Bartkova et al., 2005; Gorgoulis et al., 2005) , and these may therefore be useful not only as biomarkers, but as potential therapeutic targets, as with H2AX phosphorylation.
Summary and future perspectives
A picture is beginning to emerge about changes in chromatin structure that occur during tumourigenesis. Obviously, only a subset of these changes will be part of the cellular response to DNA damage, whose loss may contribute to 'enabling' tumourigenesis. At the moment, one major focus has been on changes to the patterns of covalent modifications on histone proteins. While this information is fundamentally important, it will also be critical to examine more complex chromatin changes. While not addressed here, the importance of ATPdependent remodelling activities in DDR has also been recognized and is intimately related to the modification pattern of chromatin (for review, see Downs et al., 2007) . But additionally, proteins such as linker histones and HMG proteins, which have received less attention, will need to be more thoroughly investigated with regard to their role in both DDR and tumourigenesis. Finally, it will be important not only to more thoroughly identify and investigate these changes in chromatin structure, but also to dissect out changes that are part of the DDR from those involved in other cellular activities that may change during the course of tumourigenesis.
